Medilink North of England News 2019 Medilink NOE News 2019 | Page 13

BRESMED HQ
HEALTH ECONOMICS
CONSULTANCY, BRESMED,
OFFICIALLY LAUNCHES
NEW GLOBAL HQ
BresMed’s new global HQ, at Steel City House in Sheffield,
is the heart of the company’s worldwide operation. The
health economics consultancy supports pharmaceutical
companies and medical device manufacturers to identify,
evaluate and demonstrate the clinical and economic value
of their products to healthcare providers.
Medilink member, Bresmed has come a long way since Nic
Brereton, the company’s CEO, moved into a one-person
office in the city many years ago. From 2014 to 2017 a
significant period of expansion saw employee numbers
increase and offices open worldwide. Further office space
was taken at North Church House until the decision was
made last year to begin the transition to a larger location at
Steel City House.
The healthcare solutions company’s bond with Sheffield
is clear when you see meeting rooms named after the
region’s icons such as Ennis, Jarvis and Hendos. The new
head office is set up to allow great IT connectivity with the
company’s other sites in Dublin, Manchester, Gurugram,
Utrecht and Las Vegas.
CEO Nic Brereton said, “I am so proud to be expanding
BresMed to these premium premises in the city. The
building very much fits with our brand – it’s iconic with a
quirky feel and, like us, it dares to be different.”
Learn more at www.bresmed.com
HART BIOLOGICALS LTD
Medilink North of England welcomes Hart Biologicals Ltd
as a new member. Founded in 2002 in Hartlepool, Hart
Biologicals moved into purpose built facilities in 2009, has
become involved in all areas of Coagulation and Platelet
Aggregation, and built up an extensive global network from
South America to Asia.
LIGHTOX APPOINTS
EXPERIENCED NON-
EXECUTIVE DIRECTORS AND
CLOSES INVESTMENT ROUND
Light-based medical start-up, LightOx revealed the
appointment of two new Non-Exectuvie Directors,
alongside their successfully closing of a 7 figure funding
round.
Mr Paul Lelieveld and Dr Frans van Dalen have joined the
North East based company, to support the development
of new light-activated drugs and fluorescent probes being
produced at the company.
The addition of these two new Non-Executive Directors
provides LightOx with further expert knowledge in the
pharmaceutical development, regulatory pathways and the
investment community – which will continue their growth.
LightOx also successfully closed its current funding round
with Dutch Biopharma specialists, Meneldor acting as
the lead. The medical start-up’s investment will aid the
commercialisation of LightOx Probes in research markets
and the development of new drugs for head, neck and skin
cancers.
The growing company, established in 2016, has been
researching novel compounds that have a unique function
within our cells for over 8 years.
LightOx CEO, Dr Sam Whitehouse, said: “We are delighted
to welcome Paul and Frans to the team.
“Their wealth of experience will help us to accelerate our
activities in both commercialising our LightOx Probes
to a global customer base, and our development of new
therapeutics which are activated by light.
“We look forward to a long and productive future with our
new NEDs.”
Non-Executive Director, Mr Paul Lelieveld, added: “We are
pleased to announce our investment in LightOx Ltd.
“We very much look forward to working with the highly
experienced management team, and together bringing
multiple LightOx-based medicines to patients in the
future.”
Learn more at www.lightox.co.uk
The Hartlepool facility is engaged in the research,
development, manufacture, and marketing of a range
of ‘ in-vitro’ diagnostic products for use in the detection,
prevention, and monitoring of a number of medical
conditions related to haemostasis and platelet function.
Hart Biologicals’ expertise, robust quality system, solid
infrastructure, dedicated staff, and state-of-the-art
manufacturing facilities have attracted partners ranging
from small start-up companies and universities to
large multi-national corporations.
Learn more by visiting https://www.hartbio.co.uk/
13